School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Int J Med Sci. 2020 Feb 4;17(3):354-367. doi: 10.7150/ijms.41155. eCollection 2020.
Diabetes mellitus (DM) causes impaired wound healing by affecting one or more of the biological mechanisms of hemostasis, inflammation, proliferation, and remodeling and a large number of cell types, extracellular components, growth factors, and cytokines. Interventions targeted toward these mechanisms might accelerate the wound healing process. To evaluate the wound healing efficacy of supercritical carbon dioxide (scCO)-decellularized porcine acellular dermal matrix (ADM) combined with autologous adipose-derived stem cells (ASCs) in streptozotocin (STZ)-induced DM rats. DM was induced by injecting rats with STZ; dorsal full-thickness skin (5 × 5 cm) was created and treated with and without ASCs-scCO-treated ADM to evaluate the wound healing rate through histological examination, fluorescence microscopic observation, and immunohistochemical analysis. In the present study, complete decellularization of the porcine dermal matrix was achieved through scCO. Isolation of ASCs was conducted and evaluated using CD29/CD31/CD45/CD90 markers in flow cytometry, which indicated that more than 90% of cells were ASCs. The percentage of cells labeled with CD29 and CD90 was found to be 97.50% and 99.69%, respectively. The wound healing rate increased in all groups relative to the group with the DM wound without treatment. DM wound treated with ADM-ASCs showed significantly higher ( < 0.01) wound healing rate than DM wound without treatment. ADM-ASC-treated rats showed significantly increased epidermal growth factor, Ki67, and prolyl 4-hydroxylase and significantly decreased CD45 compared with the group with the DM wound without treatment. The intervention comprising ADM decellularized from porcine skin by using scCO and ASCs was proven to improve diabetic wound healing. ADM-ASCs had a positive effect on epidermal regeneration, anti-inflammation, collagen production and processing, and cell proliferation; thus, it accelerated wound healing.
糖尿病(DM)通过影响止血、炎症、增殖和重塑的一个或多个生物学机制以及大量的细胞类型、细胞外成分、生长因子和细胞因子,导致伤口愈合受损。针对这些机制的干预措施可能会加速伤口愈合过程。评估超临界二氧化碳(scCO)脱细胞猪脱细胞真皮基质(ADM)联合自体脂肪来源干细胞(ASCs)在链脲佐菌素(STZ)诱导的 DM 大鼠中的伤口愈合效果。通过注射 STZ 诱导大鼠 DM;创建并处理背部全层皮肤(5×5cm),并用和不用 ASCs-scCO 处理的 ADM 处理,通过组织学检查、荧光显微镜观察和免疫组织化学分析评估伤口愈合率。在本研究中,通过 scCO 实现了猪真皮基质的完全脱细胞化。通过流式细胞术使用 CD29/CD31/CD45/CD90 标志物对 ASCs 进行分离和评估,结果表明超过 90%的细胞为 ASCs。标记有 CD29 和 CD90 的细胞百分比分别为 97.50%和 99.69%。与未治疗的 DM 伤口组相比,所有组的伤口愈合率均增加。用 ADM-ASC 治疗的 DM 伤口的愈合率明显高于未治疗的 DM 伤口(<0.01)。与未治疗的 DM 伤口组相比,ADM-ASC 治疗的大鼠表皮生长因子、Ki67、脯氨酰 4-羟化酶明显增加,CD45 明显减少。证明用 scCO 从猪皮中脱细胞化的 ADM 和 ASCs 的干预措施改善了糖尿病伤口愈合。ADM-ASC 对表皮再生、抗炎、胶原蛋白产生和处理以及细胞增殖有积极影响,从而加速了伤口愈合。